Irbesartan
Who holds supplier records for Irbesartan? 28 organisations hold a current record for Irbesartan: an active US FDA Type II Drug Master File or a CEP. A further 13 organisations have only historical (inactive) DMF filings. 21 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (20), China (4), Netherlands (1), Hungary (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Irbesartan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/irbesartan
Reading the evidence
- 28 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
20 of the 27 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 15 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (28)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Irbesartan. Country is the organisation's recorded country, not necessarily the manufacturing site.
- TAPI NL BVNetherlandsCEPActive DMF 17394, 25483 · latest filing Nov 2011
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 20378 · latest filing Mar 2007
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 23084 · latest filing Aug 2009
- Divis LaboratoriesIndiaCEP Company GMP cert on recordActive DMF 39096, 26418 · latest filing Nov 2023
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 20008 · latest filing Dec 2006
- EUROAPI HUNGARY LTDHungaryCEPActive DMF 19690 · latest filing Aug 2006
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 17507, 24665 · latest filing Feb 2011
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 19790 · latest filing Sept 2006
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 23449 · latest filing Jan 2010
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 17912 · latest filing Dec 2004
- MSN LIFE SCIENCES PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 36068 · latest filing Jul 2021
- SYNERGENE ACTIVE INGREDIENTS PVT LTDIndiaCEPActive DMF 38956 · latest filing Oct 2023
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 23835 · latest filing Jun 2010
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 21780, 21754 · latest filing Jun 2008
- ZHUHAI RUNDU PHARMACEUTICAL CO LTDChinaCEPActive DMF 32803, 25509 · latest filing Nov 2019
- Calyx Chemicals & Pharmaceuticals Ltd.India Company GMP cert on recordActive DMF 24017 · latest filing Jul 2010
- CTX LIFE SCIENCES PVT LTDIndiaActive DMF 24596 · latest filing Apr 2011
- MICRO LABS LTDIndia Company GMP cert on recordActive DMF 24834 · latest filing Mar 2011
- Piramal Pharma LimitedIndia Company GMP cert on recordActive DMF 26684 · latest filing Dec 2012
- ULKAR KIMYA SANAYII VE TICARET ASActive DMF 25861 · latest filing Mar 2012
- Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.ChinaActive DMF 24752 · latest filing Mar 2011
- Zydus Lifesciences LimitedIndia Company GMP cert on recordActive DMF 20361 · latest filing Mar 2007
- IndiaCEP
- FranceCEP Company GMP cert on record
- IndiaCEP Company GMP cert on record
- ChinaCEP
- VERDANT LIFE SCIENCES PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- CPL PHARMACEUTICALS PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (21)
Certificates of Suitability on the EDQM register for Irbesartan, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 37 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TAPI NL B.V. Amsterdam | NL | CEP 2011-251 - Rev 08 Irbesartan | Oct 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2010-124 - Rev 10 Irbesartan | May 2026 | — |
| VERDANT LIFE SCIENCES PRIVATE LIMITED Anakapalli | IN | CEP 2023-281 - Rev 00 Irbesartan | Feb 2026 | Inspected Oct 2024 Germany |
| SYNERGENE ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad | IN | CEP 2023-330 - Rev 00 Irbesartan | Jan 2026 | — |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2011-087 - Rev 06 Irbesartan | Jan 2026 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2011-046 - Rev 07 Irbesartan | Nov 2025 | — |
| CTX LIFESCIENCES PVT. LIMITED Surat | IN | CEP 2011-139 - Rev 07 Irbesartan | Nov 2025 | — |
| CPL PHARMACEUTICALS PRIVATE LIMITED Ahmedabad | IN | CEP 2023-237 - Rev 01 Irbesartan, Form-A | Jun 2025 | — |
| ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2025-025 - Rev 00 Irbesartan, Process II | May 2025 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | CEP 2023-404 - Rev 00 Irbesartan, Form-A | Apr 2025 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2011-153 - Rev 05 Irbesartan | Feb 2025 | — |
| SANOFI WINTHROP INDUSTRIE Gentilly | FR | CEP 2024-269 - Rev 00 Irbesartan, Process II | Dec 2024 | — |
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2011-151 - Rev 03 Irbesartan | Nov 2024 | — |
| EUROAPI HUNGARY Ltd. Budapest | HU | CEP 2020-101 - Rev 04 Irbesartan, CHINOIN | Oct 2024 | Inspected Jul 2026 Hungary |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2024-170 - Rev 00 Irbesartan, Form A | Aug 2024 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2017-104 - Rev 04 Irbesartan | Mar 2024 | — |
| ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Zhuhai City | CN | CEP 2017-151 - Rev 05 Irbesartan | Mar 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2021-297 - Rev 01 Irbesartan, Process II | Dec 2023 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | R1-CEP 2010-195 - Rev 08 Irbesartan | Apr 2023 | — |
| MSN LIFE SCIENCES PRIVATE LIMITED Chandampet Village | IN | R0-CEP 2021-351 - Rev 00 Irbesartan | Jan 2023 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R1-CEP 2010-033 - Rev 03 Irbesartan | May 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (13)
Organisations whose Type II DMFs for Irbesartan are no longer active. These show a past filing, not current supply.
Show all 13 historical records
- China · Inactive DMF 26802 · filed Jan 2013
- India · Inactive DMF 25446 · filed Nov 2011
- India · Inactive DMF 23398, 20198 · filed Mar 2010
- SIGNA SA DE CVInactive DMF 23347 · filed Dec 2009
- India · Inactive DMF 20176 · filed Dec 2008
- India · Inactive DMF 21369 · filed Dec 2007
- India · Inactive DMF 20148 · filed Jan 2007
- Spain · Inactive DMF 18746 · filed Sept 2005
- RANBAXY LABORATORIES LTDInactive DMF 17796 · filed Oct 2004
- BASF PHARMA EVIONNAZ SAInactive DMF 15406 · filed Apr 2001
- USA · Inactive DMF 13265, 12882 · filed Oct 1998
- Germany · Inactive DMF 13004 · filed May 1998
- France · Inactive DMF 10310 · filed Jun 1993
Overview
Irbesartan is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1513).
Chemical identity
- IUPAC name
- 2-butyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-1,3-diazaspiro[4.4]non-1-en-4-one
- Canonical SMILES
- CCCCC1=NC2(CCCC2)C(=O)N1CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5
- InChIKey
- YOSHYTLCDANDAN-UHFFFAOYSA-N
- Synonyms
- Aprovel, Avapro, BMS-186295, Ifirmasta, Irbesartan, Irbesartan bms, Irbesartan component of avalide, Irbesartan component of coaprovel, Irbesartan component of ibersartan/hydrochlorothiazide ibersartan, Irbesartan component of ibersartan/hydrochlorothiazide teva ibersartan, Irbesartan component of ibersartan/hydrochlorothiazide zentiva ibersartan, Irbesartan component of ifirmacombi
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Angiotensin 2 Receptor Blocker
- Mechanism of action
- Angiotensin 2 Receptor Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Irbesartan?
28 organisations hold an active US FDA Type II Drug Master File or a CEP for Irbesartan: TAPI NL BV (Netherlands), Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), Divis Laboratories (India), Dr. Reddy's Laboratories Ltd. (India), EUROAPI HUNGARY LTD (Hungary), Hetero Labs Limited (India) and JUBILANT BIOSYS LTD (India), and 20 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Irbesartan Drug Master Files are active?
TAPI NL BV (DMF 17394, 25483), Alembic Pharmaceuticals Limited (DMF 20378), APITORIA PHARMA PRIVATE LTD (DMF 23084), Divis Laboratories (DMF 39096, 26418), Dr. Reddy's Laboratories Ltd. (DMF 20008), EUROAPI HUNGARY LTD (DMF 19690), Hetero Labs Limited (DMF 17507, 24665) and JUBILANT BIOSYS LTD (DMF 19790) and 14 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Irbesartan records mean?
13 organisations have only inactive Type II DMFs for Irbesartan. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Irbesartan have a European Certificate of Suitability?
Yes. 21 organisations hold a valid CEP for Irbesartan on the EDQM register, including TAPI NL B.V. Amsterdam (NL), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), VERDANT LIFE SCIENCES PRIVATE LIMITED Anakapalli (IN), SYNERGENE ACTIVE INGREDIENTS PRIVATE LIMITED Hyderabad (IN), JUBILANT BIOSYS LIMITED Mysuru (IN) and MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN) and 15 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Irbesartan supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Irbesartan?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.